Being the second deadliest cancer worldwide, the role of other cholesterol-lowering drugs on Akt signaling in colorectal cancer is required to explore and understand for better understanding of the mechanism of cholesterol-lowering drugs in the prevention of colorectal cancer. The gene discussed is AKT1; the disease is cancer.